CHROMID? S AUREUS AGAR 43371

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2016-05-19 for CHROMID? S AUREUS AGAR 43371 manufactured by Biomerieux Sa.

Event Text Entries

[45527271] Device not returned to manufacturer.
Patient Sequence No: 1, Text Type: N, H10


[45527272] A customer in france notified biom? Rieux of a discrepant result associated with chromid? S. Aureus agar (reference (b)(4)). The customer reported an absence of growth for a s. Aureus strain after 48 hours of incubation. The strain was isolated on cos anc media. The customer indicated that the false result was not reported to a physician; however, the result was delayed for 24 hours. An internal biom? Rieux investigation will be initiated.
Patient Sequence No: 1, Text Type: D, B5


[46134770] A customer in (b)(6) notified biom? Rieux of a discrepant result associated with chromid s. Aureus agar (reference 43371) involving absence of growth for a s. Aureus strain after 48 hours of incubation. An internal biom? Rieux investigation was performed with results as follows: retention sample of customer's lot (1004624450) and two random lots (1004639390/same manufacturing date and 1004875030/recent manufacture date) were tested with strains s. Aureus atcc 25923, s. Aureus atcc 6538, s. Xylosus atcc 29971 and s. Saprophyticus atcc 15305. Results- after 18-24 hour incubation at 33-37? C, the performance was within specifications for all strains without differences between lots regarding: numeration, size of colony and intensity of color. S. Aureus atcc 25923 and s. Aureus atcc 6538 produced the expected colony appearance. Both developed a spontaneous green coloration whereas, s. Xylosus atcc 29971 and s. Saprophyticus atcc 15305 were not able to produce glucosidase activity. Complaint trending was reviewed; no critical issues regarding product performance were detected. Review of raw data related to manufacturing process and quality control steps was performed. All specifications met and no observations or non-conformities found that could explain the performance problem reported by the customer. Biom? Rieux requested the strain from the customer; however, it was not possible to submit the strain. Based upon the results of the internal investigation, chromid s. Aureus agar is performing in accordance with product specifications.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3002769706-2016-00090
MDR Report Key5667095
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2016-05-19
Date of Report2016-05-12
Date Mfgr Received2016-05-12
Date Added to Maude2016-05-19
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. RYAN LEMELLE
Manufacturer Street595 ANGLUM ROAD
Manufacturer CityHAZELWOOD MO 63042
Manufacturer CountryUS
Manufacturer Postal63042
Manufacturer Phone3147318582
Manufacturer G1BIOMERIEUX, INC
Manufacturer Street595 ANGLUM ROAD
Manufacturer CityST. LOUIS MO 63042
Manufacturer CountryUS
Manufacturer Postal Code63042
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCHROMID? S AUREUS AGAR
Generic NameCHROMID? S AUREUS AGAR
Product CodeJWX
Date Received2016-05-19
Catalog Number43371
Lot Number1004624450
Device Expiration Date2016-05-23
OperatorHEALTH PROFESSIONAL
Device Availability*
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBIOMERIEUX SA
Manufacturer AddressCHEMIN DE L ORME MARCY L ETOILE, RHONE 69280 FR 69280


Patients

Patient NumberTreatmentOutcomeDate
10 2016-05-19

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.